These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 7891764)

  • 1. [Screening for breast cancer after the age of 70: effect on breast cancer mortality].
    van Dijck JA; Verbeek AL; Hendriks JH; Holland R
    Ned Tijdschr Geneeskd; 1995 Mar; 139(9):428-33. PubMed ID: 7891764
    [No Abstract]   [Full Text] [Related]  

  • 2. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
    Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
    J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for breast cancer in India--is it an appropriate strategy?
    Moss S
    J Natl Cancer Inst; 2008 Sep; 100(18):1270-1. PubMed ID: 18780862
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cost-effectiveness analysis of breast cancer screening with mammography].
    Iinuma T
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():226-8. PubMed ID: 17682158
    [No Abstract]   [Full Text] [Related]  

  • 5. A model-based comparison of breast cancer screening strategies: mammograms and clinical breast examinations.
    Shen Y; Parmigiani G
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):529-32. PubMed ID: 15734983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of mammography for older women.
    Finucane TE
    Ann Intern Med; 2004 May; 140(10):844; author reply 844. PubMed ID: 15148077
    [No Abstract]   [Full Text] [Related]  

  • 7. Supporting statements and rationale.
    Costanza ME; Annas GJ; Brown ML; Cassel CK; Champion V; Cohen HJ; Frame PS; Glasse L; Mor V; Pauker SG
    J Gerontol; 1992 Nov; 47 Spec No():7-16. PubMed ID: 1430887
    [No Abstract]   [Full Text] [Related]  

  • 8. [Breast cancer screening lacking effectiveness].
    Giard RW; Bonneux LG
    Ned Tijdschr Geneeskd; 2001 Nov; 145(46):2205-8. PubMed ID: 11757241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of service screening on breast cancer mortality rates.
    Cox B
    Eur J Cancer Prev; 2008 Aug; 17(4):306-11. PubMed ID: 18562953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L; Hakama M
    Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammographic screening: does it work?
    Handler S
    Minn Med; 2003 Dec; 86(12):6-7. PubMed ID: 14719608
    [No Abstract]   [Full Text] [Related]  

  • 12. Breast cancer screening, outside the population-screening program, of women from breast cancer families without proven BRCA1/BRCA2 mutations: a simulation study.
    Jacobi CE; Nagelkerke NJ; van Houwelingen JH; de Bock GH
    Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):429-36. PubMed ID: 16537697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The muddle over screening breast Ca.
    Thomas P
    Med World News; 1988 May; 29(9):34-6, 42, 47-8. PubMed ID: 10312486
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of screening programme on mortality from breast cancer. Investment in treatment would be more cost effective.
    Baum M; Tobias JS
    BMJ; 2000 Dec; 321(7275):1528. PubMed ID: 11118189
    [No Abstract]   [Full Text] [Related]  

  • 15. Mammoscam.
    Randal J
    N C Med J; 1993 May; 54(5):194-5; discussion 196-9. PubMed ID: 8510774
    [No Abstract]   [Full Text] [Related]  

  • 16. Breast cancer screening--right or wrong?
    Chamberlain J
    Trans Med Soc Lond; 1990-1991; 107():53-7. PubMed ID: 2152425
    [No Abstract]   [Full Text] [Related]  

  • 17. The feasibility of breast cancer screening.
    Health Technol; 1987; 1(1):26-37. PubMed ID: 10311915
    [No Abstract]   [Full Text] [Related]  

  • 18. The use of life expectancy in cancer screening guidelines. Moving with caution from model-based evidence to evidence-based guidelines.
    Lantz PM; Ubel PA
    J Gen Intern Med; 2005 Jun; 20(6):552-3. PubMed ID: 15987335
    [No Abstract]   [Full Text] [Related]  

  • 19. Radiation risk and mammographic screening of women from 40 to 49 years of age: effect on breast cancer rates and years of life.
    Mattsson A; Leitz W; Rutqvist LE
    Br J Cancer; 2000 Jan; 82(1):220-6. PubMed ID: 10638993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What are the benefits and costs of screening mammograms on Kentucky women aged 40-49?
    Spratt JS; Gaines BM; Aaron WS; Cerrito P
    J Surg Oncol; 1996 Oct; 63(2):71-6. PubMed ID: 8888797
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.